NCT06930664View on ClinicalTrials.gov

A Study of Sotatercept (MK-7962) in Healthy Females Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation (MK-7962-027)

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

146

Participants

Timeline

Start Date

May 16, 2025

Primary Completion Date

November 19, 2025

Study Completion Date

November 19, 2025

Conditions

Healthy

Interventions

BIOLOGICAL

Sotatercept

Subcutaneous Injection

BIOLOGICAL

Sotatercept Autoinjector

Subcutaneous Auto Injection

Trial Locations (4)

33143

QPS-MRA, LLC ( Site 0004), South Miami

33147

Advanced Pharma CR, LLC ( Site 0005), Miami

65802

Bio-Kinetic Clinical Applications, LLD dba QPS-MO ( Site 0003), Springfield

92801

Anaheim Clinical Trials ( Site 0007), Anaheim

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT06930664 - A Study of Sotatercept (MK-7962) in Healthy Females Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation (MK-7962-027) | Biotech Hunter | Biotech Hunter